5J7B

The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 Kinase, GSK583 complex


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.53 Å
  • R-Value Free: 0.233 
  • R-Value Work: 0.180 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase.

Haile, P.A.Votta, B.J.Marquis, R.W.Bury, M.J.Mehlmann, J.F.Singhaus, R.Charnley, A.K.Lakdawala, A.S.Convery, M.A.Lipshutz, D.B.Desai, B.M.Swift, B.Capriotti, C.A.Berger, S.B.Mahajan, M.K.Reilly, M.A.Rivera, E.J.Sun, H.H.Nagilla, R.Beal, A.M.Finger, J.N.Cook, M.N.King, B.W.Ouellette, M.T.Totoritis, R.D.Pierdomenico, M.Negroni, A.Stronati, L.Cucchiara, S.Ziokowski, B.Vossenkamper, A.MacDonald, T.T.Gough, P.J.Bertin, J.Casillas, L.N.

(2016) J.Med.Chem. 59: 4867-4880

  • DOI: 10.1021/acs.jmedchem.6b00211
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • RIP2 kinase is a central component of the innate immune system and enables downstream signaling following activation of the pattern recognition receptors NOD1 and NOD2, leading to the production of inflammatory cytokines. Recently, several inhibitors ...

    RIP2 kinase is a central component of the innate immune system and enables downstream signaling following activation of the pattern recognition receptors NOD1 and NOD2, leading to the production of inflammatory cytokines. Recently, several inhibitors of RIP2 kinase have been disclosed that have contributed to the fundamental understanding of the role of RIP2 in this pathway. However, because they lack either broad kinase selectivity or strong affinity for RIP2, these tools have only limited utility to assess the role of RIP2 in complex environments. We present, herein, the discovery and pharmacological characterization of GSK583, a next-generation RIP2 inhibitor possessing exquisite selectivity and potency. Having demonstrated the pharmacological precision of this tool compound, we report its use in elucidating the role of RIP2 kinase in a variety of in vitro, in vivo, and ex vivo experiments, further clarifying our understanding of the role of RIP2 in NOD1 and NOD2 mediated disease pathogenesis.


    Organizational Affiliation

    Platform Technology and Science, GlaxoSmithKline, Medicines Research Centre , Stevenage, SG1 2NY, UK.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Receptor-interacting serine/threonine-protein kinase 2
A, B
326Homo sapiensMutation(s): 0 
Gene Names: RIPK2 (CARDIAK, RICK, RIP2)
EC: 2.7.11.1
Find proteins for O43353 (Homo sapiens)
Go to Gene View: RIPK2
Go to UniProtKB:  O43353
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
6GD
Query on 6GD

Download SDF File 
Download CCD File 
A, B
6-(tert-butylsulfonyl)-N-(5-fluoro-2H-indazol-3-yl)quinolin-4-amine
C20 H19 F N4 O2 S
XLOGLWKOHPIJLV-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.53 Å
  • R-Value Free: 0.233 
  • R-Value Work: 0.180 
  • Space Group: P 32 2 1
Unit Cell:
Length (Å)Angle (°)
a = 132.381α = 90.00
b = 132.381β = 90.00
c = 107.280γ = 120.00
Software Package:
Software NamePurpose
REFMACphasing
MOSFLMdata reduction
REFMACrefinement
SCALAdata scaling

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2016-05-18
    Type: Initial release
  • Version 1.1: 2016-06-08
    Type: Database references